surgerypartners.com (SGRY): O‘sishni hisobga olgan narx-foyda koeffitsiyenti
Surgery Partners, Inc. (SGRY) samaradorligi tajribali tibbiyot mutaxassislaridan iborat xodimlar jamoasiga asoslangan bo'lib, ularsiz markazlarning faoliyati imkonsiz bo'lar edi. Klinikalar ulushlarining jarrohlar tomonidan egalik qilinishi xodimlarning sodiqligini va statsionar muassasalardan bemorlar oqimining barqarorligini kafolatlaydi. Daromadlar ambulator oftalmologiya va ortopedik shifoxonalar tarmog'i orqali shakllantiriladi. Bashorat qilingan o'sishga nisbatan P/E koeffitsiyenti bozor muvozanatini namoyish etadi, bunda 14.98 metriki aksiyalarning jozibadorligini baholash uchun maqsadli daraja vazifasini o'taydi.
Surgery Partners, Inc. (SGRY) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy kotirovkalar va o'rtacha qiymat prognozi:
- birja kapitallashuvi ma'lumotlari:
- biznesning balans baholash tafsilotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning kapitalga nisbati Surgery Partners, Inc.|SGRY - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati surgerypartners.com|SGRY - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Surgery Partners Corp|SGRY - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Surgery Partners|Oraliq qoplash koeffitsiyenti surgerypartners.com
- foyda va bozor koeffitsiyentlari statistikasi:
SGRY - Sof daromad|Kutilayotgan sof foyda Surgery Partners, Inc.|SGRY - Narx-foyda koeffitsiyenti|Kelajakdagi narx-foyda multiplikatori Surgery Partners Group|SGRY - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniya qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Surgery Partners Corp|SGRY - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Surgery Partners|SGRY - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi surgerypartners.com|SGRY - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Surgery Partners, Inc.
Kompaniyaning umumiy tahlili:Surgery Partners, Inc.
Ushbu tendentsiya bozor qiymatining foyda o'sish sur'atlariga sezgirligini aks ettiradi, bunda birdan past qiymatlar aktivning o'sishiga nisbatan qadrsizlanganligini anglatadi. Ushbu metrika PEG ko'rsatkichi bilan tasdiqlanganidek, Surgery Partners, Inc. (SGRY) kompaniyasining noyob jarrohlar egaligidagi klinika modelini hisobga olgan holda, kapitalizatsiya samaradorligini baholaydi.
Raqobatdosh kompaniyalar
HCA - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati Tenet THC|FMS: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|SOLV: Narx-foyda va o‘sish multiplikatori|encompasshealth.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|uhsinc.com (UHS) - Narxning foydaga va o‘sish sur’atiga nisbati|DVA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori RDNT|PEG multiplikatori Option Care Corp|Narxning foydaga va o‘sish sur’atiga nisbati Premier, Inc. (PINC)|EYE (nationalvision.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori PGNY (Progyny)|Narxning sof foyda o‘sishiga nisbati Ardent Health|Select Medical Corp - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Astrana Corp|mednax.com (MD) - Narxning foydaga va o‘sish sur’atiga nisbati|U.S. Physical Therapy, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori PNTG|O‘sish sur’atiga tuzatilgan narx-foyda Organogenesis Holdings Inc. ORGO|Narx-foyda va o‘sish multiplikatori NUTX (Nutex Health Corp)|AUNA (Auna Corp) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati SBC Medical Group Holdings Inc SBC|EOLS (evolus.com) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Community Health Systems, Inc. - PEG multiplikatori|SKIN - PEG multiplikatori|mediwound.com (MDWD) - Narxning foydaga va o‘sish sur’atiga nisbati|Biote Corporation - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narx-foyda va o‘sish multiplikatori JYNT|DCGO (docgo.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati P3 Health Partners Inc. (PIII)|Gain Therapeutics Inc. - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori EUDA (EUDA Health)|Basel Medical (BMGL) - O‘sish sur’atiga tuzatilgan narx-foyda|CLGN - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CUPR (cuprina.com.sg)|Concord Medical (CCM) - Narxning foydaga va o‘sish sur’atiga nisbati|AMS - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori MRM|ALBT: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori DHAI|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati carmellcosmetics.com|Narxning foydaga va o‘sish sur’atiga nisbati NewGenIvf NIVF|ATIP: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|CareMax Medical Group - PEG multiplikatori|Kindly Health (KDLY) - Narx-foyda va o‘sish multiplikatori|MODV (ModivCare Inc.) - Narx-foyda va o‘sish multiplikatori|NVOS - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati SunLink Health Systems Inc.|IMAC Holdings Inc (BACK) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
